| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2002 | US20020111337 Use of an aldosterone receptor antagonist to improve cognitive function |
| 08/15/2002 | US20020111336 Topical composition |
| 08/15/2002 | US20020111335 Bactericides, bacteriostats |
| 08/15/2002 | US20020111334 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 08/15/2002 | US20020111333 Hypotensive agents; cardiovascular disorders |
| 08/15/2002 | US20020111332 Alpha-substituted beta-aminoethyl phosphonate derivatives |
| 08/15/2002 | US20020111329 Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
| 08/15/2002 | US20020111328 Anticancer, antitumor agent |
| 08/15/2002 | US20020111327 Method and compositions for treating the inflammatory response |
| 08/15/2002 | US20020111319 2-halogenated derivatives of 5-0-desosaminyl-erythronolide A, their preparation process and their antibiotic use |
| 08/15/2002 | US20020111316 Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors |
| 08/15/2002 | US20020111315 Synergistic mixture with antilipemic agent |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111300 Methods for reduced renal uptake of protein conjugates |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020111292 Bone disorders, alopesia |
| 08/15/2002 | US20020111291 Diabetic therapy |
| 08/15/2002 | US20020110898 Attenuating endogenous genes in cell; obtain cell, transform with vectors conding restriction enzymes, recover and propagate transformed cells |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110873 Process for the production of lipstatin and tetrahydrolipstatin |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110638 Substrate with a photocatalytic coating |
| 08/15/2002 | US20020110606 Chlorogenic acid and an analog thereof for immune system stimulation |
| 08/15/2002 | US20020110601 Antineoplastic platinum therapeutic method and composition |
| 08/15/2002 | US20020110599 Dissolving or dispersing active compounds in aqueous or colloidal dispersion of a proteinaceous protecting colloid, flocculating with active compound out of dispersion separating off flocculated solid; forming dry powder |
| 08/15/2002 | US20020110598 Growth stimulant compositions |
| 08/15/2002 | US20020110597 Redispersibility upon administration to human or animal |
| 08/15/2002 | US20020110595 Slow release pharmaceutical compositions |
| 08/15/2002 | US20020110594 Antibiotic/benzoyl peroxide dispenser |
| 08/15/2002 | US20020110590 Pharmaceutical formulation containing DEMO for the treatment of cancer |
| 08/15/2002 | US20020110586 Liposomal antineoplastic drugs and uses thereof |
| 08/15/2002 | US20020110579 Use of prenylated flavones |
| 08/15/2002 | US20020110578 Sublingual buccal effervescent |
| 08/15/2002 | US20020110577 Method and non-gelling composition for inhibiting post-surgical adhesions |
| 08/15/2002 | US20020110575 Can be incorporated into a matrix, such as a paint or other coating composition, provide the matrix with resistance to fouling by organisms of more than one type; for use in shampoo, skin care products |
| 08/15/2002 | US20020110570 Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type |
| 08/15/2002 | US20020110569 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110560 Lowering elevated post-prandial blood glucose levels in mammals by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110537 Topically applying on a skin a composition including an adsorbent which adsorbs at least a component of an urushiol oil for minimizing Rhus dermatitis |
| 08/15/2002 | US20020110535 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 08/15/2002 | US20020110531 Cholesterol reducing composition and method of making the same |
| 08/15/2002 | US20020110530 For reducing the presence of microorganism; for use in mouthrinse, soaps, dentrifice, deodorant formulations |
| 08/15/2002 | US20020110529 Inhalable powder containing tiotropium |
| 08/15/2002 | US20020110528 Stability, aerosols, drug delivery; therapy |
| 08/15/2002 | US20020110527 Stability, aerosols, drug delivery; therapy |
| 08/15/2002 | US20020110526 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110525 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110479 2-phenylphenol and natural and/or synthetic thymol dissolved in a isopropyl alcohol |
| 08/15/2002 | US20020109025 Generating fine medicament powders suitable for inhalation using a fluid energy milling with milling fluid such as air or nitrogen at a controlled relative humidity 30-50%; triamcinolone acetonide or salbutamol sulfate |
| 08/15/2002 | CA2796884A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2685214A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2442343A1 Method of treating neurological disorders using acetone derivatives |
| 08/15/2002 | CA2441948A1 Glycine betaine and its use as anti-hemorrhagic agent |
| 08/15/2002 | CA2438221A1 Steroidal derivatives |
| 08/15/2002 | CA2437630A1 Method for producing a floating tablet containing an active principle |
| 08/15/2002 | CA2437480A1 Method of treating amyloid .beta. precursor disorder |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2437375A1 Methods and compositions for reducing the taste of pharmaceutically active agents |
| 08/15/2002 | CA2437372A1 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | CA2437353A1 Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437215A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 08/15/2002 | CA2437212A1 Methods and devices for tissue repair |
| 08/15/2002 | CA2437087A1 Methods for the administration of amifostine and related compounds |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | CA2436490A1 Use of xylyloxy alkyl amines in the treatment of tinnitus |
| 08/15/2002 | CA2436467A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
| 08/15/2002 | CA2436465A1 Prediction of wound healing by urinary nitrate assay |
| 08/15/2002 | CA2436461A1 Pyridine-substituted benzanilides as potassium ion channel openers |
| 08/15/2002 | CA2436374A1 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | CA2435989A1 Pharmaceutical composition for the therapy of lower urinary tract symptoms |
| 08/15/2002 | CA2435982A1 Medicaments |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | CA2435546A1 Rapid-onset medicament for the treatment of sexual dysfunction |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2435350A1 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
| 08/15/2002 | CA2434566A1 Parenteral formulation containing epothilone analogs |
| 08/15/2002 | CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods |
| 08/15/2002 | CA2434079A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/15/2002 | CA2432188A1 Thiazole derivatives for treating ppar related disorders |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231219A1 GLucagon-like peptide-2 analogs |
| 08/14/2002 | EP1231218A2 An appetite-suppressing peptide, its compositions and use |
| 08/14/2002 | EP1231213A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |